Clinical Study to Evaluate the Efficacy and Safety of a Cosmetic Product in Subjects With Telogen Effluvium and Androgenic Alopecia
Conditions: Telogen Effluvium, Androgenetic Alopecia
Sponsor: Lacer S.A.

 
 
 
Clinical study to evaluate the effects and safety of a cosmetic product in 
participants with telogen eﬄuvium and androgenic alopecia 
Protocol ID: LACER_2406_COS 
Date: 04Feb2025 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Study synopsis 
 
The study was aimed to assess the eﬃcacy of a cosmetic product (shampoo) in 
reducing the visible signs of hair loss in subjects with telogen eﬄuvium and 
androgenetic alopecia.  In order to reach this goal, a prospective, observational 
study was carried out on 40 healthy female and male subjects between 18 and 
65 years old, with hair loss due to telogen eﬄuvium and androgenetic alopecia.   
Speciﬁc eﬃcacy assessments were carried out before and after 1 month and 3 
months of product use. The occurrence of adverse events was also recorded. 
The study was approved by an independent ethics committee, and no protocol 
amendments were done after the approval.